This Article Full Text (PDF) Other Versions of this Article: AAC.01057-06v1 51/2/616    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nelson, J. L. Articles by Somerville, G. A. Search for Related Content PubMed PubMed Citation Articles by Nelson, J. L. Articles by Somerville, G. A.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.01057-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Vancomycin-Intermediate Staphylococcus aureus have Impaired Acetate Catabolism: Implications for Polysaccharide Intercellular Adhesin Synthesis and Autolysis

Department of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198; Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298; Public Health Research Institute, 225 Warren Street, Newark, NJ 07103

^* To whom correspondence should be addressed. Email: gsomerville3{at}unl.edu.

	Abstract

The most common mechanism by which Staphylococcus aureus gains resistance to vancomycin is by adapting its physiology and metabolism to permit growth in the presence of vancomycin. Several studies have examined the adaptive changes occurring during the transition to vancomycin-intermediate resistance, leading to a model of vancomycin resistance in which decreased cell wall turnover and autolysis result in increased cell wall thickness and resistance to vancomycin. In the present study, we identified metabolic changes common to vancomycin-intermediate S. aureus (VISA) strains by assessing the metabolic and growth characteristics of two VISA strains (vancomycin MICs of 8 µg/ml) and two isogenic derivative strains with vancomycin MICs of 32 µg/ml. Interestingly, we observed the parental strains had impaired catabolism of non-preferred carbon sources (i.e., acetate), and this impairment became more pronounced as vancomycin resistance increased. To determine if acetate catabolism impairment was common to VISA strains, we assessed the ability of VISA and vancomycin-sensitive S. aureus (VSSA) clinical isolates to catabolize acetate. As expected, a significantly greater percentage of VISA strains (71%) had impaired acetate catabolism relative to VSSA (8%). This is an important observation because staphylococcal acetate catabolism is implicated in growth yield, antibiotic tolerance, and in regulating cell death and polysaccharide intercellular adhesin (PIA) synthesis.

This article has been cited by other articles:

• Rice, K. C., Bayles, K. W. (2008). Molecular Control of Bacterial Death and Lysis. Microbiol. Mol. Biol. Rev. 72: 85-109 [Abstract] [Full Text]  
• Meehl, M., Herbert, S., Gotz, F., Cheung, A. (2007). Interaction of the GraRS Two-Component System with the VraFG ABC Transporter To Support Vancomycin-Intermediate Resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51: 2679-2689 [Abstract] [Full Text]